Showing results (151-160 of 426) with videos related to
Sort By:
Pageof 43
Investigative Radiology|March 10, 2023
ComBat Harmonization for MRI Radiomics: Impact on Nonbinary Tissue Classification by Machine LearningDoris Leithner, Rachel B Nevin, Peter Gibbs, et al.JAMA Health Forum|May 31, 2024
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage PlansYonghong Li, Avneet K Heer, Hillary S Sloane, et al.Asia-Pacific Journal of Clinical Oncology|May 16, 2019
Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancerTimothy Price, Lin Shen, Brigette Ma, et al.Journal of Pain and Symptom Management|July 5, 2014
Comparison of ECOG/WHO performance status and ASA score as a measure of functional statusJane Young, Tim Badgery-Parker, Timothy Dobbins, et al.ANZ Journal of Surgery|August 6, 2014
Outcomes in the surgical treatment of low rectal cancer: does neoadjuvant treatment equalize results?William G Pollett, Peter Gibbs, Stephen McLaughlin, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2019
Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphomaMarius E Mayerhoefer, Christopher C Riedl, Anita Kumar, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 4, 2015
Registration of Supine MR Mammography with Breast Ultrasound for Surgical Planning of Breast Conserving Surgery: A Feasibility StudyMartin D Pickles, Peter Gibbs, Anne Hubbard, et al.ANZ Journal of Surgery|November 20, 2004
Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experienceBrett G M Hughes, Desmond Yip, Michael Chao, et al.Asia-Pacific Journal of Clinical Oncology|June 28, 2018
Re-inventing the randomized controlled trial in medical oncology: The registry-based trialSiavash Foroughi, Hui-Li Wong, Lucy Gately, et al.Chemotherapy|December 9, 2008
A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patientsPeter Gibbs, Tracey J Brown, Raymond Ng, et al.Pageof 43